Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PP-01 in Cannabis Use Disorder
NCT05494437Phase 2Completed
- Sponsor
- PleoPharma, Inc.
- Start
- Oct 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PP-01 in cannabis withdrawal, sponsored by PleoPharma, Inc.. Started Oct 2022; status: completed.
02
Drugs
PP-01
03
Conditions
cannabis withdrawal
Beyond the preview
Go deeper on NCT05494437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494437.